London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias

Installation of Stereotaxis Niobe(R) and Odyssey(TM) Systems Further Royal Brompton and Harefield NHS Trust's Leadership Role in the Treatment of Complex Heart Conditions ST. LOUIS, June 24 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced that Briti...

Royal Brompton Hospital Finds A New Technique To Detect Child Heart Killer

A new technique developed by cardiologists of Royal Brompton Hospital helps in determining the risk of sudden death due to weakness in heart of young people. The// process involves injecting a dye called gadolinium into the patient's vein and then scanning for the results using MRI (Magnetic Reson...

TriReme Medical, Inc. Receives CE Marking for Glider(TM) PTCA Dilatation Catheter

...he side branch. The unique characteristics of the Glider(TM) are designed to overcome these limitations," said Professor Carlo Di Mario from the Royal brompton Hospital in London. "I am pleased to be working with TriReme as they develop products specifically tailored for the treatment of bifurcation disease."...

Telemonitoring changes the working practice of cardiac nurses

...cusp of becoming mainstream, and likely to result in a major change to the working practices of heart failure nurses," says Jill Riley, from the Royal brompton Hospital, (London, UK), who is speaking in Friday's session exploring how telemonitoring can be used to enhance the self care of heart failure patient...

Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial

...ssemia patients with iron overload, which is a critical goal of treatment for these patients," said Dudley Pennell, MD, Professor of Cardiology, Royal brompton and Harefield NHS Trust and Imperial College, London. "Cardiac complications caused by the buildup of toxic iron in the heart can be life-threatening ...

Study sheds light on deadly lung disease

...the understanding of SSc, particularly as it relates to lung fibrosis, researchers with the Royal Free and University College Medical School and Royal brompton Hospital in London conducted experiments on a novel mouse model of scleroderma. Their results, published in the April 2008 issue of Arthritis & Rheuma...

Smoking Worsens Prognosis for IPF Patients

... severe -- and so current smoking is linked to milder disease," research leader Dr. Athol U. Wells, of the Interstitial Lung Disease Unit at the Royal brompton Hospital in London, said in a prepared statement. Publishing in the second issue for January of the American Journal of Respiratory and Critical C...

Smoking belies milder disease but worse prognosis for IPF patients

...e becomes more severeand so current smoking is linked to milder disease, said Athol U. Wells, M.D., of the Interstitial Lung Disease Unit at the Royal brompton Hospital in London, who headed the research. The investigators studied the medical records of 249 patients with IPF, and analyzed the extent and se...

New system for classifying infant lung disease developed

...which to base diagnoses in a uniform fashion well all be reading from the same book, said Andrew Nicholson, M.D., consultant histopathologist at Royal brompton Hospital and professor of respiratory pathology at the National Heart and Lung Institute Division of Imperial College School of Medicine in London, wh...

Restricting Blood Flow May Help Heart Bypass Patients

...red in the study by troponin release," said Dr. Henry Purcell, of the Royal brompton Hospital in London, and co-author of an accompanying editorial in the journ...iovascular Institute, University College London; Henry Purcell, M.D., Royal brompton Hospital, London; Aug. 18, 2007, The Lancet ...

Brompton in Medical Technology

Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy

...e risk of bleeding associated with these treatments has been greatly under-appreciated," said Kim Fox, M.D., F.R.C.P., Director of Cardiology at Royal brompton Hospital and Professor of Clinical Cardiology at Imperial College. "The gastrointestinal toxicity from dual antiplatelet therapy can result in patient...

Brompton in Biological News

Mechanical 'artificial hearts' can remove need for heart transplant by returning heart to normal

...archers from Imperial College London and the Royal brompton and Harefield NHS Trust gave the full combination ...the Heart Science Centre at Imperial and the Royal brompton and Harefield NHS Trust, and lead author of the st...the Heart Science Centre at Imperial and the Royal brompton and Harefield NHS Trust, said: "We are impressed b...

Monoclonal antibody reduces exacerbations in asthmatics

...ritical Care Medicine, published by the American Thoracic Society. Trevor T. Hansel, M.D., Ph.D., of the National Heart and Lung Institute at Royal brompton Hospital in London, and 11 associates infused 14 patients with infliximab, a monoclonal antibody that binds and neutralizes tumor necrosis factor alph...

Brompton in Biological Technology

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

...ean Cystic Fibrosis Conference in Brest, France. The results were presented to the conference on Friday 12 June by Dr Diana Bilton of the Royal brompton Hospital, London. The trial was a multi-centre, randomised, double blind, placebo controlled, 26 week study, with an optional further 6 month o...

Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

...tol. In a poster session Professor Di Bilton, Consultant Physician and Honorary Senior Lecturer at the Department of Respiratory Medicine, The Royal brompton Hospital, London, UK, will detail results of a successful randomized, placebo- controlled trial of inhaled mannitol (Bronchitol) in patients with bron...